SELENIUM ANTI-FR TABLETS

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

d-alpha-tocopheryl acid succinate, Quantity: 41.32 mg; selenomethionine, Quantity: 65 microgram (Equivalent: selenium, Qty 26 microgram); calcium pantothenate, Quantity: 21.8 mg (Equivalent: calcium, Qty 1.83 mg; Equivalent: pantothenic acid, Qty 20 mg); thiamine hydrochloride, Quantity: 10 mg; Allium sativum, Quantity: 2.857 mg (Equivalent: Allium sativum, Qty 50 mg); ascorbic acid, Quantity: 500 mg; pyridoxine hydrochloride, Quantity: 25 mg (Equivalent: pyridoxine, Qty 20.57 mg); zinc amino acid chelate, Quantity: 25 mg (Equivalent: zinc, Qty 5 mg); betacarotene, Quantity: 3 mg

Disponible depuis:

Mega Lifesciences (Australia) Pty Ltd

DCI (Dénomination commune internationale):

Allium sativum,Ascorbic acid,Betacarotene,Calcium pantothenate,d-alpha-Tocopheryl acid succinate,pyridoxine hydrochloride,Seleno

forme pharmaceutique:

Tablet, film coated

Composition:

Excipient Ingredients: povidone; microcrystalline cellulose; hypromellose; calcium hydrogen phosphate dihydrate; macrogol 400; colloidal anhydrous silica; croscarmellose sodium; iron oxide yellow; magnesium stearate; Carnauba Wax; titanium dioxide; maize starch; ascorbyl palmitate; Gelatin; Maize Oil; dl-alpha-tocopherol; sucrose

Mode d'administration:

Oral

indications thérapeutiques:

Antioxidant/Reduce free radicals formed in the body ; Helps reduce/decrease free radical damage to body cells ; Helps enhance/promote general health and wellbeing ; Aid/assist/helps glucose/sugar/carbohydrate metabolism

Descriptif du produit:

Visual Identification: ;

Statut de autorisation:

Licence status A

Date de l'autorisation:

2017-08-02